Back to Results
First PageMeta Content
Asthma / Dosage forms / Respiratory therapy / Phenethylamines / Salmeterol / Metered-dose inhaler / Inhaler / Fluticasone propionate / GlaxoSmithKline / Medicine / Pulmonology / Pharmacology


SKADDEN, ARPS, 1440 SLATE,
Add to Reading List

Document Date: 2005-12-01 10:46:25

Open Document

File Size: 720,13 KB

Share Result on Facebook

City

Rockville / FRANKFURT / /

Company

GlaxoSmithKline / 3M Pharmaceuticals / Schering-Plough / IVAX Corporation / Page 3 Corporation / Glaxosmithkline plc / Skadden Arps / /

Country

United States / /

Currency

USD / /

Event

FDA Phase / Product Release / /

IndustryTerm

distinct new drug applications / drug products / /

Organization

MOSCOW PARIS / Pulmonary-Allergy Drugs Advisory Committee / Food and Drug Administration / Division of Dockets Management / US Federal Reserve / Food and Drug Administration Department of Health and Human Services / /

Person

Robert J. Meyer / Wayne Mitchell / D. Wayne H. Mitchell / SYDNEY TOKYO / James A. Losey / /

/

Position

Counsel / Commissioner / representative / /

Product

fluticasone propionate / Dexamethasone / Flovent / Flunisolide / Vanceril / Triamcinolone / Beclovent / ODS beclomethasone MD1 product / Approved Drug / ODS / New Drug / MD1 / 4148T2 / Vanceril CFC / /

ProvinceOrState

Maryland / /

Technology

http / /

SocialTag